Stock TCRX TSCAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart TScan Therapeutics, Inc.

Equities

TCRX

US89854M1018

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
8.55 USD +3.14% Intraday chart for TScan Therapeutics, Inc. +1.66% +46.66%
29/05 TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status MT
29/05 TScan Therapeutics Receives FDA?s Regenerative Medicine Advanced Therapy Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies CI
74e401765a914ea0478abd9ac0d.OrE9ESaE05wszGYpL49PczRXehoB0nt47uubzi31uzs.ZeR0a3_Xp99p-Bx7d-YLLFVvDW1ihwo2lryvnhy50XB0yVthQOOEsUWtPw~1eb49ed2d7ebc813b9eb138373a4aa0e
  1. Stock Market
  2. Equities
  3. TCRX Stock
  4. Charts TScan Therapeutics, Inc.
  5. News Chart